Prokidney R&D Spending Growth & History (PROK)
Prokidney's r&d spending was $114.1M for fiscal 2025.
View full Prokidney company overviewProkidney annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $114.1M | −$13.5M | −10.61% |
| 2024 | 2024-12-31 | $127.7M | $21.0M | +19.64% |
| 2023 | 2023-12-31 | $106.7M | $24.6M | +30.02% |
| 2022 | 2022-12-31 | $82.1M | $35.8M | +77.43% |
| 2021 | 2021-12-31 | $46.3M | $25.2M | +119.82% |
| 2020 | 2020-12-31 | $21.0M | — | — |
Prokidney quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $36.1M | $10.2M | +39.46% |
| Q1 2026 | 2026-03-31 | $33.8M | $6.6M | +24.13% |
| Q4 2025 | 2025-12-31 | $34.2M | −$5.6M | −14.14% |
| Q3 2025 | 2025-09-30 | $26.8M | −$4.4M | −14.17% |
| Q2 2025 | 2025-06-30 | $25.9M | −$3.5M | −11.98% |
| Q1 2025 | 2025-03-31 | $27.3M | $30,000 | +0.11% |
| Q4 2024 | 2024-12-31 | $39.8M | $17.3M | +76.58% |
| Q3 2024 | 2024-09-30 | $31.3M | −$948,000 | −2.94% |
| Q2 2024 | 2024-06-30 | $29.4M | $3.0M | +11.53% |
| Q1 2024 | 2024-03-31 | $27.2M | $1.6M | +6.31% |
| Q4 2023 | 2023-12-31 | $22.5M | $1.6M | +7.84% |
| Q3 2023 | 2023-09-30 | $32.2M | $11.1M | +52.37% |
| Q2 2023 | 2023-06-30 | $26.4M | $14.8M | +128.10% |
| Q1 2023 | 2023-03-31 | $25.6M | −$2.9M | −10.08% |
| Q4 2022 | 2022-12-31 | $20.9M | — | — |
| Q3 2022 | 2022-09-30 | $21.1M | $6.4M | +43.35% |
| Q2 2022 | 2022-06-30 | $11.6M | — | — |
| Q1 2022 | 2022-03-31 | $28.5M | — | — |
| Q3 2021 | 2021-09-30 | $14.7M | — | — |
Prokidney r&d spending trends
Over the last five fiscal years, Prokidney's r&d spending increased from $21.0M to $114.1M, a change of $93.1M. The latest reported quarter, Q2 2026, shows $36.1M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prokidney source filings ↗